BICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD

Biosero, a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, has signed an agreement with a global life science company for a total value of 28 MUSD to design and build an automated R&D, hardware and software platform which consists of 5 sub-projects. The project is estimated to run from late Q4 2023 until Q1 2026 and the platform is aimed to shorten time for drug development workflows.

The project will run in a ramp-up phase during 2024 and the vast majority of the project will be carried out and invoiced during 2025.

“This agreement is a milestone for the Group and it’s our largest project to date. It also shows the strength in Biosero’s offering for laboratory automation solutions and we expect to shorten current timelines for drug development through automation”, says Maria Forss, President and CEO, BICO.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Biosero Inc.. (2023, December 07). BICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20231207/BICO-company-Biosero-has-signed-an-agreement-to-develop-laboratory-automation-solutions-to-a-value-of-28-MUSD.aspx.

  • MLA

    Biosero Inc.. "BICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20231207/BICO-company-Biosero-has-signed-an-agreement-to-develop-laboratory-automation-solutions-to-a-value-of-28-MUSD.aspx>.

  • Chicago

    Biosero Inc.. "BICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD". News-Medical. https://www.news-medical.net/news/20231207/BICO-company-Biosero-has-signed-an-agreement-to-develop-laboratory-automation-solutions-to-a-value-of-28-MUSD.aspx. (accessed November 21, 2024).

  • Harvard

    Biosero Inc.. 2023. BICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20231207/BICO-company-Biosero-has-signed-an-agreement-to-develop-laboratory-automation-solutions-to-a-value-of-28-MUSD.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Biosero and RORZE Lifescience collaborate to commercialize Green Button Go Automation Scheduling Software in Asia